Skip to main content
. 2023 Oct 27;6:1093. doi: 10.1038/s42003-023-05472-z

Fig. 3. UHPLC-MRM/MS analysis of FXN-M tryptic peptides.

Fig. 3

A hFXN-M from human heart left ventricle. B mFXN-M from Rhesus macaque heart left ventricle. C 50:50 mixture of hFXN-M and mFXN-M. The most intense MRM transitions for each peptide were used: SGTLGHPGSLDDTTYER (y142+), SGTLGHPGSLDETTYER (y142+), QIWLSSPSSGPKR (y8+), LGGDLGTYVINK (y10+), LDLSSLAYSGK (y10+), NWVYSHDGVSLHELLGAELTK (y193+), NWVYSHDGVSLHELLAAELTK (y193+).